A Rare Presentation of Levetiracetam-Induced Torsades De Pointes

Cureus. 2023 Jun 23;15(6):e40866. doi: 10.7759/cureus.40866. eCollection 2023 Jun.

Abstract

Torsades de pointes occurs in the presence of a prolonged QTc interval, which has many congenital and acquired causes. Levetiracetam is a widely used anti-epileptic medication secondary to its favorable safety profile. We present a rare case of a 59-year-old male who developed torsades de pointes and cardiac arrest after levetiracetam administration. To our knowledge, there is only one other case report documenting torsades de pointes after levetiracetam administration, and our case report will be the first documenting cardiac arrest after levetiracetam administration.

Keywords: cardiac arrest; drug-induced torsades de pointes; hypokalemia; hypomagnesemia; qt interval prolongation; s: levetiracetam; torsades de pointes (tdp); ventricular fibrillation.

Publication types

  • Case Reports